#dementia

1 article

1 articles

Sorted by Newest

Alzheimer's Drug Lecanemab Shows 27% Cognitive Decline Reduction in Major Clinical Trial

Alzheimer's Drug Lecanemab Shows 27% Cognitive Decline Reduction in Major Clinical Trial

Lecanemab shows 27% reduction in cognitive decline for early Alzheimer's patients. The breakthrough could transform dementia treatment worldwide.

May 17, 2026 5 min read

#alzheimers
#clinical trials
#neuroscience
#drug development